214 related articles for article (PubMed ID: 31721311)
21. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38.
Xie J; Qian J; Wang S; Freeman ME; Epstein J; Yi Q
J Immunol; 2003 Nov; 171(9):4792-800. PubMed ID: 14568957
[TBL] [Abstract][Full Text] [Related]
22. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
Traves PG; Murray B; Campigotto F; Galien R; Meng A; Di Paolo JA
Ann Rheum Dis; 2021 Jul; 80(7):865-875. PubMed ID: 33741556
[TBL] [Abstract][Full Text] [Related]
23. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells.
Maeshima K; Yamaoka K; Kubo S; Nakano K; Iwata S; Saito K; Ohishi M; Miyahara H; Tanaka S; Ishii K; Yoshimatsu H; Tanaka Y
Arthritis Rheum; 2012 Jun; 64(6):1790-8. PubMed ID: 22147632
[TBL] [Abstract][Full Text] [Related]
24. Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis.
Hashimoto T; Sakai K; Sanders KM; Yosipovitch G; Akiyama T
Acta Derm Venereol; 2019 Mar; 99(3):298-303. PubMed ID: 30460374
[TBL] [Abstract][Full Text] [Related]
25. Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations.
McInnes IB; Byers NL; Higgs RE; Lee J; Macias WL; Na S; Ortmann RA; Rocha G; Rooney TP; Wehrman T; Zhang X; Zuckerman SH; Taylor PC
Arthritis Res Ther; 2019 Aug; 21(1):183. PubMed ID: 31375130
[TBL] [Abstract][Full Text] [Related]
26. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
27. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.
Popēna I; Ābols A; Saulīte L; Pleiko K; Zandberga E; Jēkabsons K; Endzeliņš E; Llorente A; Linē A; Riekstiņa U
Cell Commun Signal; 2018 Apr; 16(1):17. PubMed ID: 29690889
[TBL] [Abstract][Full Text] [Related]
28. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.
Wang A; Rahman NT; McGeary MK; Murphy M; McHenry A; Peterson D; Bosenberg M; Flavell RA; King B; Damsky W
J Allergy Clin Immunol; 2021 May; 147(5):1795-1809. PubMed ID: 33317858
[TBL] [Abstract][Full Text] [Related]
29. Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea.
Yu J; Li P; Li Z; Li Y; Luo J; Su W; Liang D
Transl Vis Sci Technol; 2022 Mar; 11(3):34. PubMed ID: 35353151
[TBL] [Abstract][Full Text] [Related]
30. IL-10 expression in macrophages from neonates born from obese mothers is suppressed by IL-4 and LPS/INFγ.
Cifuentes-Zúñiga F; Arroyo-Jousse V; Soto-Carrasco G; Casanello P; Uauy R; Krause BJ; Castro-Rodríguez JA
J Cell Physiol; 2017 Dec; 232(12):3693-3701. PubMed ID: 28160500
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway.
Lin YH; Wang YH; Peng YJ; Liu FC; Lin GJ; Huang SH; Sytwu HK; Cheng CP
Cells; 2020 Apr; 9(4):. PubMed ID: 32290250
[TBL] [Abstract][Full Text] [Related]
32. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
[TBL] [Abstract][Full Text] [Related]
33. Elevated level of pro inflammatory cytokine and chemokine expression in chicken bone marrow and monocyte derived dendritic cells following LPS induced maturation.
Kalaiyarasu S; Bhatia S; Mishra N; Sood R; Kumar M; SenthilKumar D; Bhat S; Dass Prakash M
Cytokine; 2016 Sep; 85():140-7. PubMed ID: 27344111
[TBL] [Abstract][Full Text] [Related]
34. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.
Boyle DL; Soma K; Hodge J; Kavanaugh A; Mandel D; Mease P; Shurmur R; Singhal AK; Wei N; Rosengren S; Kaplan I; Krishnaswami S; Luo Z; Bradley J; Firestein GS
Ann Rheum Dis; 2015 Jun; 74(6):1311-6. PubMed ID: 25398374
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of JAK inhibitor on mechanical stress-induced protease expression by human articular chondrocytes.
Machida T; Nishida K; Nasu Y; Nakahara R; Ozawa M; Harada R; Horita M; Takeshita A; Kaneda D; Yoshida A; Ozaki T
Inflamm Res; 2017 Nov; 66(11):999-1009. PubMed ID: 28752178
[TBL] [Abstract][Full Text] [Related]
36. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
Morelli M; Scarponi C; Mercurio L; Facchiano F; Pallotta S; Madonna S; Girolomoni G; Albanesi C
J Immunol Res; 2018; 2018():7897263. PubMed ID: 30581877
[TBL] [Abstract][Full Text] [Related]
37. Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Weinhold KJ; Bukowski JF; Brennan TV; Noveck RJ; Staats JS; Lin L; Stempora L; Hammond C; Wouters A; Mojcik CF; Cheng J; Collinge M; Jesson MI; Hazra A; Biswas P; Lan S; Clark JD; Hodge JA
Clin Immunol; 2018 Jun; 191():10-20. PubMed ID: 29518577
[TBL] [Abstract][Full Text] [Related]
38. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.
Wei X; Wu J; Zhao G; Galdamez J; Lele SM; Wang X; Liu Y; Soni DM; Purdue PE; Mikuls TR; Goldring SR; Wang D
Mol Pharm; 2018 Aug; 15(8):3456-3467. PubMed ID: 29966420
[TBL] [Abstract][Full Text] [Related]
39. IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein.
de la Paz Sánchez-Martínez M; Blanco-Favela F; Mora-Ruiz MD; Chávez-Rueda AK; Bernabe-García M; Chávez-Sánchez L
Lipids Health Dis; 2017 Oct; 16(1):196. PubMed ID: 29017604
[TBL] [Abstract][Full Text] [Related]
40. Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features.
Magatti M; Vertua E; De Munari S; Caro M; Caruso M; Silini A; Delgado M; Parolini O
J Tissue Eng Regen Med; 2017 Oct; 11(10):2895-2911. PubMed ID: 27396853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
